Displaying drugs 7651 - 7675 of 7778 in total
PF-03758309
PF-03758309 has been used in trials studying the treatment of Advanced Solid Tumors.
Investigational
6-hydroxy-1,6-dihydro purine nucleoside
Experimental
CRA_9785
Experimental
CRA_1144
Experimental
Albendazole oxide
Experimental
Kaempherol
Experimental
CRA_9076
Experimental
Banoxantrone
Banoxantrone is a highly selective bioreductive drug that is activated in, and is preferentially toxic to, hypoxic cells in tumours. It has been shown to work synergistically with fractionated radiation to significantly delay growth of tumours compared to administration of either banoxantrone or radiation alone. Banoxantrone was also efficacious in...
Investigational
AZD-3839
AZD3839 has been used in trials studying the basic science of Safety, Tolerability, Alzheimer's Disease, and Blood Concentration.
Investigational
Anacetrapib
Investigational
Tricetin
Experimental
Displaying drugs 7651 - 7675 of 7778 in total